Piotr Andrzejewski
Overview
Explore the profile of Piotr Andrzejewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Witoszynskyj S, Andrzejewski P, Georg D, Hacker M, Nyholm T, Rausch I, et al.
Phys Med
. 2019 Aug;
65:76-83.
PMID: 31437602
Hybrid PET/MR offers new opportunities in radiation oncology for tissue/tumour characterisation and response assessment. Attenuation correction (AC) is an important issue especially in the presence of immobilization devices and flat...
2.
Andrzejewski P, Wengert G, Helbich T, Magometschnigg H, Georg D, Hacker M, et al.
Contrast Media Mol Imaging
. 2019 Feb;
2019:1307247.
PMID: 30728757
The aim of this study was to assess whether sequential multiparametric [F]fluoro-desoxy-glucose ([F]FDG)/[F]fluoromisonidazole ([F]FMISO) PET-MRI in breast cancer patients is possible, facilitates information on tumor heterogeneity, and correlates with prognostic...
3.
Daniel M, Andrzejewski P, Sturdza A, Majercakova K, Baltzer P, Pinker K, et al.
Radiother Oncol
. 2017 Nov;
125(3):420-425.
PMID: 29153465
Background And Purpose: Multimodal tissue characterization by combined MRI and PET has high clinical potential in the context of sub-target definition for dose painting and response assessment but its clinical...
4.
Kuess P, Andrzejewski P, Nilsson D, Georg P, Knoth J, Susani M, et al.
Phys Med Biol
. 2017 Aug;
62(19):7833-7854.
PMID: 28837046
The role of multi-parametric (mp)MRI in the diagnosis and treatment of prostate cancer has increased considerably. An alternative to visual inspection of mpMRI is the evaluation using histogram-based (first order...
5.
Kostiukhina N, Georg D, Rollet S, Kuess P, Sipaj A, Andrzejewski P, et al.
Phys Med Biol
. 2017 Aug;
62(20):8136-8153.
PMID: 28817381
A novel breathing phantom was designed for being used in conventional and ion-beam radiotherapy as well as for medical imaging. Accurate dose delivery and patient safety are aimed to be...
6.
Polanec S, Andrzejewski P, Baltzer P, Helbich T, Stiglbauer A, Georg D, et al.
PLoS One
. 2017 Jul;
12(7):e0180790.
PMID: 28719629
Background: The aim of this study was to evaluate whether MP [11C]Acetate PET-MRI enables an accurate differentiation of benign and malignant prostate tumors as well as local and distant staging....
7.
Georg P, Andrzejewski P, Baltzer P, Daniel M, Wadsak W, Mitterhauser M, et al.
Mol Imaging Biol
. 2017 May;
20(1):160-169.
PMID: 28540524
Purpose: Imaging biomarkers assessed with magnetic resonance imaging (MRI) and/or positron emission tomography (PET) enable non-invasive tumor characterization in cervix cancer patients. We investigated the spatio-temporal stability of hypoxia, perfusion,...
8.
Pinker K, Andrzejewski P, Baltzer P, Polanec S, Sturdza A, Georg D, et al.
PLoS One
. 2016 May;
11(5):e0155333.
PMID: 27167829
Objectives: To investigate fused multiparametric positron emission tomography/magnetic resonance imaging (MP PET/MRI) at 3T in patients with locally advanced cervical cancer, using high-resolution T2-weighted, contrast-enhanced MRI (CE-MRI), diffusion-weighted imaging (DWI),...
9.
Andrzejewski P, Kuess P, Knausl B, Pinker K, Georg P, Knoth J, et al.
Radiother Oncol
. 2015 Sep;
117(3):509-14.
PMID: 26349588
Background And Purpose: Advancements in imaging and dose delivery enable boosting of the dominant intraprostatic lesions (DIL), while maintaining organs-at-risk (OAR) tolerances. This study aimed to assess the feasibility of...
10.
Gora J, Kuess P, Stock M, Andrzejewski P, Knausl B, Paskeviciute B, et al.
Acta Oncol
. 2015 Apr;
54(8):1166-74.
PMID: 25850583
Unlabelled: Anatomical changes in the head-and-neck (H&N) region during the course of treatment can cause deteriorated dose distributions. Different replanning strategies were investigated for volumetric modulated arc therapy (VMAT) and...